Biblio

Author Title [ Type

] Year

Filters: Author is Zeinali, Sirous [Clear All Filters]

Journal Article

Fallah A, Estiri H, Parrish E, Soleimani M, Zeinali S, Zadeh-Vakili A. Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy. Cell J. 2020;21(4):433-443.

Hozhabrpour A, Mojbafan M, Palizban F, Vahidnezhad F, Talebi S, Amani M, Garshasbi M, Naghavi A, Khalesi R, Mansouri P, et al. DNA repair-related heritable photosensitivity syndromes: Mutation landscape in a multiethnic cohort of 17 multigenerational families with high degree of consanguinity. DNA Repair (Amst). 2024;136:103633.

Mashayekhi P, Noruzinia M, Zeinali S, Khodaverdi S. Endometriotic Mesenchymal Stem Cells Epigenetic Pathogenesis: Deregulation of , , and in A Functional Imbalanced Epigenetic Disease. Cell J. 2019;21(2):179-185.

Parikhani ABeig, Bagherzadeh K, Dehghan R, Biglari A, Shokrgozar MAli, Rad FRiazi, Zeinali S, Talebkhan Y, Ajdary S, Cohan RAhangari, et al. Human IL-2Rɑ subunit binding modulation of IL-2 through a decline in electrostatic interactions: A computational and experimental approach. PLoS One. 2022;17(2):e0264353.

Youssefian L, Naji M, Park JS, Rajabi F, Abdollahimajd F, Mahmoudi H, Kamyab-Hesari K, Ghalamkarpour F, Zabihi M, Teimoorian M, et al. Ichthyosis follicularis syndromes in patients with germline mutations in GJB2. Clin Exp Dermatol. 2022.

Vahidnezhad H, Youssefian L, Saeidian AHossein, Touati A, Pajouhanfar S, Baghdadi T, Shadmehri AAhmadi, Giunta C, Kraenzlin M, Syx D, et al. Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type VII collagen deficiency. Matrix Biol. 2018.

Saeidian AHossein, Youssefian L, Huang CY, Palizban F, Naji M, Saffarian Z, Mahmoudi H, Goodarzi A, Sotoudeh S, Vahidnezhad F, et al. Whole-transcriptome sequencing-based concomitant detection of viral and human genetic determinants of cutaneous lesions. JCI Insight. 2022.